Ascentage Pharma Presented at 42nd Annual J.P. Morgan Health

/PRNewswire/ -- Ascentage Pharma (6855.HK), a commercial stage global biopharmaceutical company engaged in developing novel therapies for cancer, chronic...

Related Keywords

Canada , Suzhou , Jiangsu , China , Hong Kong , Rockville , Pennsylvania , United States , Philadelphia , Australia , American , Chinese , Prnewswire Ascentage Pharma , Dajun Yang , Ascentage Pharma , National Major New Drug Development , Md Anderson Cancer Center , National Reimbursement Drug List , Drug Administration , Dana Farber Cancer Institute , American Society Of Clinical Oncology , Astrazeneca , Major National , American Society Of Hematology , China National Medical Products Administration , Drug Evaluation , Reimbursement Drug List , Annual Meeting , Oral Presentations , Oral Presentation , Doral Report , American Society , Clinical Oncology , Healthcare Conference , Main Board , Stock Exchange , Hong Kong Limited , Major National Rd Projects , Major New Drug Projects , New Drug Incubator , Innovative Drug Programs , Major Project , Priority Review Designations , Breakthrough Therapy Designations , Orphan Drug Designation , Fast Track Designation , Orphan Designation , Pediatric Disease , Cancer Center , Mayo Clinic ,